Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bionano Genomics Inc BNGO

Technology Scientific & Technical Instruments
Bionano Genomics, Inc. is a genomics company. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. Through Lineagen, Inc., the Company also provides diagnostic testing for patients with clinical presentations consistent with autism spectrum disorder and other neurodevelopmental disabilities. It also offers a platform... see more

Recent & Breaking News (NDAQ:BNGO)

Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan

GlobeNewswire October 11, 2023

Bionano Announces Pricing of $80.0 Million Registered Offering and Concurrent Private Placement of Senior Secured Convertible Notes and Warrants

GlobeNewswire October 11, 2023

Benchmarking Study Shows Streamlined Structural Variant Detection and High Concordance for OGM Compared to Chromosomal Microarray Analysis, the Global Standard in Genetic Disease Analysis

GlobeNewswire September 28, 2023

Bionano Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 22, 2023

Bionano Announces Third OEM Partner has Received China NMPA Approval for DNA Isolation Products for IVD Use of OGM

GlobeNewswire September 21, 2023

Largest Study of Mendelian Disease Highlights how OGM, alongside other Techniques, May Enhance Success Rates in Identifying Molecular Causes of Genetic Disease

GlobeNewswire September 14, 2023

Bionano Announces Peer-Reviewed Publication on the Utility of Combining OGM and WES for Evaluation of Pediatric Leukemia

GlobeNewswire September 6, 2023

Bionano Announces Publication Demonstrating Utility of OGM as an Alternative to KT and CMA for Evaluating CRISPR-Edited Cells as Part of Stem Cell Therapy Development

GlobeNewswire August 30, 2023

Bionano Announces Second OEM Partner has Received China NMPA Approval for DNA Extraction and Labeling Products for IVD Use of OGM in Reproductive Health

GlobeNewswire August 28, 2023

Bionano Regains Compliance with Nasdaq Minimum Bid Price Listing Requirement

GlobeNewswire August 21, 2023

Bionano Laboratories Receives College of American Pathologists (CAP) Accreditation for its Clinical Laboratory

GlobeNewswire August 16, 2023

Bionano Announces CFO Transition and Appointment of Gülsen Kama as Chief Financial Officer

GlobeNewswire August 14, 2023

Bionano Announces Presentation of Optical Genome Mapping (OGM) Utility Across Cancer Research Applications at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting

GlobeNewswire August 11, 2023

Bionano Reports Second Quarter 2023 Results and Highlights Recent Business Progress

GlobeNewswire August 9, 2023

Bionano Genomics Announces Reverse Stock Split

GlobeNewswire August 4, 2023

Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023

GlobeNewswire August 2, 2023

Bionano Announces OGM Roadshow, TOUR, which Provides Education on the Company's Workflow and Helps Build a Community of Users

GlobeNewswire July 31, 2023

Bionano to Present at the Canaccord Genuity 43rd Annual Growth Conference

GlobeNewswire July 27, 2023

Bionano Announces the Stratys(TM) System for OGM and VIA(TM) Software for Hematologic Malignancies

GlobeNewswire June 29, 2023

Bionano to Present at the Healthcare Virtual Conference

GlobeNewswire June 21, 2023